EUVIMEDEUVIMED entdecken
Leserbrief

Increased incidence of co-trimoxazole-induced rash in patients on systemic corticosteroid treatment for toxicity associated with immune checkpoint inhibitors

Daniel Yiu, Silvia Aguilar-Duran, Charlotte Edwards, Dharmisha Chauhan, Andrew Furness, Samra Turajlic, James Larkin, Louise Fearfield, Kara Heelan iD

British Journal of Dermatology · 2024

DOI: 10.1093/bjd/ljae202 ↗

Kurz gefasst

Leserbrief in der Zeitschrift British Journal of Dermatology, 2024. Verfasst von Daniel Yiu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Solihull Dermatology Department, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Drug Eruptions, Trimethoprim, Sulfamethoxazole Drug Combination. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 8 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Our cross-sectional study demonstrates that there is a high rate of co-trimoxazole-induced drug rash in patients treated for immune-related adverse events, with those developing rash appearing to have a reduced survival.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immune Checkpoint InhibitorsDrug EruptionsTrimethoprim, Sulfamethoxazole Drug CombinationHumansMaleFemaleMiddle AgedAgedIncidenceExanthemaRetrospective StudiesAdrenal Cortex HormonesGlucocorticoids

Substanzen

Immune Checkpoint InhibitorsTrimethoprim, Sulfamethoxazole Drug CombinationAdrenal Cortex HormonesGlucocorticoids

Autor:innen und Institutionen

  • Solihull Dermatology Department, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Royal Marsden Hospital, London, UK.
  • Department of Dermatology, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.
  • Cancer Dynamics Laboratory, Francis Crick Institute, London, UK.

ORCID-Profile: Kara Heelan

Zitieren

APA

Yiu, D., Aguilar-Duran, S., Edwards, C., Chauhan, D., Furness, A., Turajlic, S., Larkin, J., Fearfield, L., & Heelan, K. (2024). Increased incidence of co-trimoxazole-induced rash in patients on systemic corticosteroid treatment for toxicity associated with immune checkpoint inhibitors. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljae202

Vancouver

Yiu D, Aguilar-Duran S, Edwards C, Chauhan D, Furness A, Turajlic S, et al. Increased incidence of co-trimoxazole-induced rash in patients on systemic corticosteroid treatment for toxicity associated with immune checkpoint inhibitors. British Journal of Dermatology. 2024. doi:10.1093/bjd/ljae202

BibTeX
@article{Yiu2024,
  author = {Yiu, Daniel and Aguilar-Duran, Silvia and Edwards, Charlotte and Chauhan, Dharmisha and Furness, Andrew and Turajlic, Samra and Larkin, James and Fearfield, Louise and Heelan, Kara},
  title = {Increased incidence of co-trimoxazole-induced rash in patients on systemic corticosteroid treatment for toxicity associated with immune checkpoint inhibitors},
  journal = {British Journal of Dermatology},
  year = {2024},
  doi = {10.1093/bjd/ljae202}
}
Kostenlos starten →